✨ Your Portfolio is fetched and updated from zerodha.

Natco Pharma Ltd.

NATCOPHARM

Market Cap
₹22,125 Cr.
P/E
11.38

Natco Pharma Ltd.

  • Natco Pharma
  • Pfizer
  • Astrazeneca Pharma I
  • TJI Pharma
FAQs on Natco Pharma Ltd. Shareprice

Natco Pharma has given lower returns compared to its competitors.
Natco Pharma has grown at ~7.91% over the last 4yrs while peers have grown at a median rate of 17.71%

Natco Pharma is not expensive.
Latest PE of Natco Pharma is 11.38, while 3 year average PE is 30.98.
Also latest EV/EBITDA of Natco Pharma is 8.74 while 3yr average is 23.33.

View FAQ's On Business
Growth Table
  • Natco Pharma Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Balance Sheet
  • Natco Pharma Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Natco Pharma Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Cash Flow
  • Natco Pharma Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Natco Pharma Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Quarterly Results
  • Natco Pharma Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Natco Pharma Ltd. Financials

Balance sheet of Natco Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Natco Pharma is increasing.
Latest debt of Natco Pharma is -₹1,361.1 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹1,542.3 Crs.

Yes, profit is increasing.
The profit of Natco Pharma is ₹1,944 Crs for TTM, ₹1,388 Crs for Mar 2024 and ₹715 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Natco Pharma latest dividend payout ratio is 12.25% and 3yr average dividend payout ratio is 24.86%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech